Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551327/
https://www.ncbi.nlm.nih.gov/pubmed/37811306
http://dx.doi.org/10.1155/2023/9859381
_version_ 1785115740427255808
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10551327
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105513272023-10-06 Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-09-27 /pmc/articles/PMC10551327/ /pubmed/37811306 http://dx.doi.org/10.1155/2023/9859381 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title_full Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title_fullStr Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title_full_unstemmed Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title_short Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
title_sort retracted: lncrna agap2-as1 facilitates tumorigenesis and ferroptosis resistance through slc7a11 by igf2bp2 pathway in melanoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551327/
https://www.ncbi.nlm.nih.gov/pubmed/37811306
http://dx.doi.org/10.1155/2023/9859381
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedlncrnaagap2as1facilitatestumorigenesisandferroptosisresistancethroughslc7a11byigf2bp2pathwayinmelanoma

Ejemplares similares